Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J McCormick

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Elife|June 10, 2020
Modulation of dopamine D<sub>1</sub> receptors via histamine H<sub>3</sub> receptors is a novel therapeutic target for Huntington's diseaseDavid Moreno-Delgado, Mar Puigdellívol, Estefanía Moreno, et al.
Journal of Medicinal Chemistry|November 9, 2017
A Positive Allosteric Modulator of the Serotonin 5-HT<sub>2C</sub> Receptor for ObesityJavier García-Cárceles, Juan M Decara, Henar Vázquez-Villa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 2015
Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaineGemma Navarro, César Quiroz, David Moreno-Delgado, et al.
Neuropharmacology|November 16, 2013
L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleusJordi Bonaventura, Alberto J Rico, Estefanía Moreno, et al.
The Journal of Biological Chemistry|April 18, 2024
Cryo-EM structure of human HCN3 channel and its regulation by cAMPBo Yu, Qiuyuan Lu, Jian Li, et al.
Glia|July 28, 2016
The insulin-like growth factor I receptor regulates glucose transport by astrocytesEdwin Hernandez-Garzón, Ana M Fernandez, Alberto Perez-Alvarez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 20, 2017
Singular Location and Signaling Profile of Adenosine A<sub>2A</sub>-Cannabinoid CB<sub>1</sub> Receptor Heteromers in the Dorsal StriatumEstefanía Moreno, Anna Chiarlone, Mireia Medrano, et al.
ACS Central Science|May 27, 2024
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse AgonistsMiroslav Kosar, Roman C Sarott, David A Sykes, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2019
Therapeutic targeting of HER2-CB<sub>2</sub>R heteromers in HER2-positive breast cancerSandra Blasco-Benito, Estefanía Moreno, Marta Seijo-Vila, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 6, 2021
Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse BrainCarlos Costas-Insua, Estefanía Moreno, Irene B Maroto, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Elife|June 10, 2020
Modulation of dopamine D<sub>1</sub> receptors via histamine H<sub>3</sub> receptors is a novel therapeutic target for Huntington's diseaseDavid Moreno-Delgado, Mar Puigdellívol, Estefanía Moreno, et al.
Journal of Medicinal Chemistry|November 9, 2017
A Positive Allosteric Modulator of the Serotonin 5-HT<sub>2C</sub> Receptor for ObesityJavier García-Cárceles, Juan M Decara, Henar Vázquez-Villa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 2015
Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaineGemma Navarro, César Quiroz, David Moreno-Delgado, et al.
Neuropharmacology|November 16, 2013
L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleusJordi Bonaventura, Alberto J Rico, Estefanía Moreno, et al.
The Journal of Biological Chemistry|April 18, 2024
Cryo-EM structure of human HCN3 channel and its regulation by cAMPBo Yu, Qiuyuan Lu, Jian Li, et al.
Glia|July 28, 2016
The insulin-like growth factor I receptor regulates glucose transport by astrocytesEdwin Hernandez-Garzón, Ana M Fernandez, Alberto Perez-Alvarez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 20, 2017
Singular Location and Signaling Profile of Adenosine A<sub>2A</sub>-Cannabinoid CB<sub>1</sub> Receptor Heteromers in the Dorsal StriatumEstefanía Moreno, Anna Chiarlone, Mireia Medrano, et al.
ACS Central Science|May 27, 2024
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse AgonistsMiroslav Kosar, Roman C Sarott, David A Sykes, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2019
Therapeutic targeting of HER2-CB<sub>2</sub>R heteromers in HER2-positive breast cancerSandra Blasco-Benito, Estefanía Moreno, Marta Seijo-Vila, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 6, 2021
Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse BrainCarlos Costas-Insua, Estefanía Moreno, Irene B Maroto, et al.
Pageof 10